Beyond histological remission: the role of mucosal calprotectin as a potential predictor of outcomes in ulcerative colitis.

Guirgis, M; Wendt, E; Wang, L; Walsh, A; Burger, D; Bryant, R; Kent, A; Adamson, R; Brain, O; Travis, S; Keshav, S

Neuroscience & Neuroimaging Research Collection

Journal article

Beyond histological remission: the role of mucosal calprotectin as a potential predictor of outcomes in ulcerative colitis.

Abstract:: Background
Histological remission and low faecal calprotectin are positive prognostic factors in ulcerative colitis (UC). Intramucosal calprotectin (iMC), which can be readily determined by immunohistochemistry, has not so far been evaluated as a predictor of outcome in UC.

Aims
To investigate the relationship between iMC and clinical, endoscopic and histological measures of remission in UC, and the independent prognostic value of iMC.

Method
Ambulant patients with UC were recruited for a study comparing clinical activity indices. Sigmoidoscopy and biopsy were performed at the index visit. Clinical, endoscopic and histological activity was scored and iMC semi-quantitatively measured using immunohistochemistry for the S100A8/9 heterodimer on colonic biopsies, scored as the mean number of positive cells in five high power fields (HPF). At the end of follow up (six years), data on steroid use, hospitalisation, and colectomy (‘adverse outcomes’) were collected.

Results
iMC was determined in 83 patients and 20 controls, and correlated with clinical, endoscopic and histological activity (r=0.51, 0.65, 0.53 p>0.001, respectively). iMC was lowest (median 2.4, IQR: 5.2-5 p<0.001) in patients with concordance between clinical, endoscopic and histological remission. Median iMC>5/HPF was associated with adverse outcome (HR 3.36 CI 1.58-7.15, p<0.001). Only 53%, 33%, and 25% of patients in histological remission with iMC >5cells/HPF avoided an adverse outcome after 1, 3 and 6 years respectively.

Conclusion
iMC was lowest in patients with concordant clinical, endoscopic and histological remission. Median iMC >5/HPF was associated with adverse outcomes despite histological remission. Therefore iMC is a potentially useful independent marker of activity.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Guirgis, M., Wendt, E., Wang, L., Walsh, A., Burger, D., Bryant, R., Kent, A., Adamson, R., Brain, O., Travis, S., & Keshav, S. (2016). Beyond histological remission: the role of mucosal calprotectin as a potential predictor of outcomes in ulcerative colitis. Journal of Crohn's and Colitis.

MLA Style

Guirgis, M, et al. “Beyond Histological Remission: the Role of Mucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis.” Journal of Crohn's and Colitis, 2016.

Chicago Style

Guirgis, M, E Wendt, L Wang, et al. 2016. “Beyond Histological Remission: the Role of Mucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis.” Journal of Crohn's and Colitis.
Print